FindTrial
Sign In

Use of Autolog for cell salvage to prevent complications of blood loss in liposuctions

Use of Autolog system to prevent complications of blood loss in liposuctions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9tr6hb4
Enrollment
Unknown
Registered
2024-03-06
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Loss, Surgical

Interventions

The main objective is to evaluate the use of blood recover system Autolog in patients submitted to liposuctions, double blinded, randomized with two branches. A experimental group of 32 patients that
E04.936.537.687

Sponsors

Hospital Agamenon Magalhaes
Lead Sponsor
Hospital Agamenon Magalhaes
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 to 60; both genders; approved by the hospital's medical board for liposuction

Exclusion criteria

Exclusion criteria: diabetes mellitus; heart problems; vascular diseases; history of previous surgery in the same area; therapy with anticoagulant; replacement with blood products in the last 90 days

Design outcomes

Primary

MeasureTime frame
Improvement in post-operative hemoglobin levels with a quicker return of patients to their routine life, adding safety to the procedure—

Secondary

MeasureTime frame
No secondary outcomes are expected—

Countries

Brazil

Contacts

Public ContactLuiz Felipe Fernandes Vieira

Hospital Agamenon Magalhaes

luizfelipedfv@uol.com.br+558131841600

Outcome results

None listed

Source: REBEC (via WHO ICTRP)